(Q35134241)

6 August 2017

1 reference

title

Heart disease in diabetic patients. (English)

1 reference

6 August 2017

1 reference

Mihaela C Blendea

1

1 reference

6 August 2017

Samy I McFarlane

2

1 reference

6 August 2017

Esma R Isenovic

3

1 reference

6 August 2017

Gregory Gick

4

1 reference

6 August 2017

James R Sowers

5

1 reference

6 August 2017

publication date

1 June 2003

1 reference

6 August 2017

published in

Current diabetes report

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

223-229

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-003-0068-z

6 August 2017

exact match

0 references

cites work

Diabetes, hypertension, and cardiovascular disease: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0068-Z

Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0068-Z

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0068-Z

Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0068-Z

Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0068-Z

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0068-Z

Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-003-0068-Z

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

12 December 2020

Influence of cardiac autonomic neuropathy on heart rate dependence of ventricular repolarization in diabetic patients.

1 reference

12 December 2020

Diabetes and cardiovascular disease.

1 reference

12 December 2020

The role of PCI and CABG in the management of coronary artery disease in patients with diabetes

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

The effect of adjusting for baseline risk factors and post revascularisation coronary disease on comparisons between coronary angioplasty and bypass surgery

1 reference

12 December 2020

Silent coronary artery disease in diabetes--a feature of autonomic neuropathy or accelerated atherosclerosis?

1 reference

12 December 2020

Oxidative stress and diabetic cardiomyopathy: a brief review

1 reference

12 December 2020

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project

1 reference

12 December 2020

A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women

1 reference

12 December 2020

Hypertension, angiotensin II, and oxidative stress

1 reference

12 December 2020

Impaired fasting glucose, blood pressure and cardiovascular disease mortality

1 reference

12 December 2020

Increased activity of endogenous endothelin in patients with type II diabetes mellitus

1 reference

12 December 2020

Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model

1 reference

12 December 2020

Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond

1 reference

12 December 2020

Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study

1 reference

12 December 2020

Do atherosclerosis and type 2 diabetes share a common inflammatory basis?

1 reference

12 December 2020

Cardiac sympathetic dysinnervation in Type 2 diabetes mellitus with and without ECG-based cardiac autonomic neuropathy

1 reference

12 December 2020

Diabetes mellitus and cardiovascular disease in women

1 reference

12 December 2020

A new look at the heart in diabetes mellitus: from ailing to failing

1 reference

12 December 2020

Sudden cardiac death in the United States, 1989 to 1998.

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

Cardiomyocyte dysfunction in sucrose-fed rats is associated with insulin resistance

1 reference

12 December 2020

Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.

1 reference

12 December 2020

Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program

1 reference

12 December 2020

Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

The relationship of plasma glucose and electrocardiographic parameters in elderly women with different degrees of glucose tolerance.

1 reference

12 December 2020

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

1 reference

12 December 2020

Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy

1 reference

12 December 2020

Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension

1 reference

12 December 2020

Targeting the use of glycoprotein IIb/IIIa antagonists--the diabetic patient.

1 reference

12 December 2020

Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II- dependent

1 reference

12 December 2020

Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group

1 reference

12 December 2020

Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study

1 reference

12 December 2020

Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Myocardial cell death in human diabetes

1 reference

12 December 2020

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

1 reference

12 December 2020

1999 Clinical Advisory Treatment of Hypertension and Diabetes

1 reference

12 December 2020

Insulin-like growth factor I as a cardiac hormone: physiological and pathophysiological implications in heart disease

1 reference

12 December 2020

Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers

1 reference

12 December 2020

Elevated plasma endothelin-1 levels in diabetes mellitus

1 reference

12 December 2020

Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status

1 reference

12 December 2020

Albuminuria and Poor Glycemic Control Predict Mortality in NIDDM

1 reference

12 December 2020

Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats

1 reference

12 December 2020

Aldosterone and D-glucose stimulate the proliferation of human cardiac myofibroblasts in vitro

1 reference

12 December 2020

Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year

1 reference

12 December 2020

Altered cardiac excitation-contraction coupling in ventricular myocytes from spontaneously diabetic BB rats.

1 reference

12 December 2020

Protein kinase C and the development of diabetic vascular complications

1 reference

12 December 2020

Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.

1 reference

12 December 2020

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

12 December 2020

Potential role of advanced glycosylation end products in promoting restenosis in diabetes and renal failure

1 reference

12 December 2020

AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

12 December 2020

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

1 reference

12 December 2020

Diabetic cardiomyopathy: fact or fiction?

1 reference

12 December 2020

Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry

1 reference

12 December 2020

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

12 December 2020

Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association

1 reference

12 December 2020

Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode

1 reference

12 December 2020

Early failure of the diabetic heart

1 reference

12 December 2020

Coronary heart disease in patients with diabetes

1 reference

12 December 2020

10.1007/S11892-003-0068-Z

Identifiers

DOI

1 reference

release_txea66mi6vcazfbevgbd7tyq2u

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/txea66mi6vcazfbevgbd7tyq2u

24 November 2022

mapped directly with Wikidata item

1 reference